FDA Inspection
Haupt Pharma Amareg GmbHHaupt Pharma Amareg GmbH – FDA Inspection, Nov 10, 2017
Record Details
This FDA Inspection record concerns Haupt Pharma Amareg GmbH, with an inspection on November 10, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ff1d6434-13f7-4c0d-9c4d-3797bdc4ffbc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1038904
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Haupt Pharma Amareg GmbH
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2011 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Haupt Pharma Amareg GmbH
- FDA Inspection 1274881 - 2024-07-26
- FDA Inspection 1134674 - 2019-06-07
- FDA Inspection 986248 - 2016-08-26
- FDA Inspection 857318 - 2013-11-22
- FDA Inspection 727709 - 2011-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.